EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine As a Potential Booster Vaccine Option for Adults in the United StatesK. Paret,H. Beyhaghi,W. Herring,M. Rousculp,S. Toback,J. MauskopfValue in Health（2022）引用 0|浏览18AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
